Ennovabio

PharmaceuticalsSeries BShanghai, Chinaennovabio.com

Latest round

Series B

Last raised

Oct 2025

Total raised

$14M

Investors

8

About Ennovabio

Founded in 2016 and based in Shanghai, China, Ennovabio operates as a drug research and development company that focuses on antitumor field. 50% of the company's employees have a doctoral degree and 80% members have master's degree. Dr., Ltd. The company provides new anti-tumor drugs and treatment methods for patients. The company develops anti-tumor new drug development platform that bases on combination targeting strategy. The company focuses on tumors, autoimmune diseases and inflammatory diseases field. The core technology of the company includes medicinal chemistry, bioinformatics and statistics. The company will accelerate its R&D pipeline and provide more breakthrough solutions for the treatment of complex diseases.

Who invested in Ennovabio

8 investors across 3 rounds

See all investors in Ennovabio

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Oct 13, 2025

    Amount

    Undisclosed

    Investors

    Locked

  2. Series B

    Sep 26, 2021

    Amount

    Undisclosed

    Investors

    Locked

  3. Series A

    Nov 28, 2019

    Amount

    $14M

    Investors

    Locked

Questions about Ennovabio

Who invested in Ennovabio?

Ennovabio has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Ennovabio raised?

Ennovabio has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did Ennovabio last raise money?

Ennovabio's most recent round on record is a Series B, in Oct 2025.

What does Ennovabio do?

Founded in 2016 and based in Shanghai, China, Ennovabio operates as a drug research and development company that focuses on antitumor field.

Where is Ennovabio headquartered?

Ennovabio is headquartered in Shanghai, China.

Which VCs invest in companies like Ennovabio?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at Ennovabio's stage. Their profiles are linked below.

Raising like Ennovabio? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.